In 2022, Dr. Maura Abbott, Associate Professor of Nursing at the Columbia University School of Nursing, served as faculty for i3 Health’s CME/NCPD approved activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia. Now, in this follow-up interview with Oncology Data Advisor, Dr. Abbott reinforces the importance of educating patients who are at risk for chemotherapy-induced neutropenia and shares some of the therapeutic developments in both prevention and management that are coming down the pipeline in the near future.

Listen to the free CME/NCPD activity, New Insights Into Preventing and Managing Chemotherapy-Induced Neutropenia, after the interview and click here to claim credit: i3health.com/44-policies/503-i3health-com-cin

Faculty Interview & Free CME/NCPD Activity: Chemotherapy-Induced Neutropenia

i3 Health is pleased to be hosting Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer (TNBC): Case Explorations and Answers to FAQs, a live webinar, on July 12, 2023 at 1:00 pm EST, chaired by Dr. Sara Tolaney and Dr. Ira Bleiweiss. In this video interview, Dr. Tolaney shares a preview of the important topics she will be discussing in the webinar, including approaches to treatment selection, the emerging role of novel therapies, timely management of adverse events, and much more. Watch the video to gain insight into the factors Dr. Tolaney takes into account in the management of TNBC, and register for the webinar on July 12 to hear the complete discussion!

Expert Perspectives in the Management of Triple-Negative Breast Cancer:Webinar Preview, Sara Tolaney

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

New tracks tagged #nursing continuing professional development